Communicable Diseases, Emerging: Clinical Trials

1 trial for Communicable Diseases, Emerging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Communicable Diseases, Emerging: new trials by email Literature Review of Communicable Diseases, Emerging trials Research Report on Communicable Diseases, Emerging

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies
ERVEBO Vaccination - Ebola, Bundibugyo Virus Disease (BVD)
Phase 4RecruitingEpicentre200002026-09-192026-10-29

Narrower conditions

Hemorrhagic Fever, Ebola (1)

Broader conditions

Communicable Diseases (1)  ·  Disease Attributes (1)  ·  Filoviridae Infections (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Infections (1)  ·  Mononegavirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  RNA Virus Infections (1)  ·  Virus Diseases (1)

Sponsors

Epicentre (1)

Countries

Democratic Republic of the Congo (1)